Release 4B Ballot #1

This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Evidencevariable-example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort.json

Clinical Decision Support Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Not linked to any defined compartments

Raw JSON (canonical form + also see JSON Format Specification)

Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis

{
  "resourceType": "EvidenceVariable",
  "id": "example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <p>\n        Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis\n      </p>\n\t</div>"
  },
  "name": "Stroke Thrombolysis Trialists’ 2014-2016 IPD-MA Cohort",
  "title": "Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis",
  "status": "draft",
  "useContext": [
    {
      "code": {
        "system": "http://terminology.hl7.org/CodeSystem/usage-context-type",
        "code": "focus"
      },
      "valueCodeableConcept": {
        "text": "Stroke"
      }
    }
  ],
  "relatedArtifact": [
    {
      "type": "citation",
      "label": "Emberson 2014",
      "display": "Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.",
      "citation": "Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063",
      "url": "https://doi.org/10.1016/S0140-6736(14)60584-5"
    },
    {
      "type": "citation",
      "label": "Lees 2016",
      "display": "Figure 2 Lees 2016",
      "citation": "Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, et al; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016;47:2373-2379. PMID 27507856",
      "url": "https://doi.org/10.1161/STROKEAHA.116.013644"
    }
  ],
  "actual": true,
  "characteristicCombination": "union",
  "characteristic": [
    {
      "definitionReference": {
        "reference": "Group/ECASSIII-Trial-Cohort",
        "type": "Group",
        "display": "ECASS III Trial Cohort"
      }
    },
    {
      "definitionReference": {
        "reference": "Group/IST3-Trial-Cohort",
        "type": "Group",
        "display": "IST3 Trial Cohort"
      }
    },
    {
      "definitionReference": {
        "reference": "Group/ECASS-Trial-Cohort",
        "type": "Group",
        "display": "ECASS Trial Cohort"
      }
    },
    {
      "definitionReference": {
        "reference": "Group/ECASSII-Trial-Cohort",
        "type": "Group",
        "display": "ECASSII Trial Cohort"
      }
    },
    {
      "definitionReference": {
        "reference": "Group/EPITHET-Trial-Cohort",
        "type": "Group",
        "display": "EPITHET Trial Cohort"
      }
    },
    {
      "definitionReference": {
        "reference": "Group/ATLANTIS-Trial-Cohort",
        "type": "Group",
        "display": "ATLANTIS Trial Cohort"
      }
    },
    {
      "definitionReference": {
        "reference": "Group/NINDS-Trial-Cohort",
        "type": "Group",
        "display": "NINDS Trial Cohort"
      }
    }
  ]
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.